Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

EMB vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, EMB returned −0.4% to IBB's +37.5%, and EMB charges 0.39% to IBB's 0.44%.

askIQ about this page

askIQ about EMB and IBB

Net assets: $13.2bn on Oct 28, 2026 for iShares J.P. Morgan USD Emerging Markets Bond ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
−0.4%
EMB total return, 1 year
+37.5%
IBB total return, 1 year
0.39%
EMB expense ratio
0.44%
IBB expense ratio

Pair scorecard

EMB costs 0.05 points a year less; their one-year returns differ by 37.9 points; EMB is 1.2 times larger.

EMB vs IBB: Differences, Returns & Fees
MeasureEMBIBB
Return
Total return, 1 year−0.4%+37.5%
Drawdown
Below its high3.5%, high on Jun 29, 2026
Benchmark
What it tracksJ.P. Morgan EMBI Global Core IndexBiotech
Cost and size
Expense ratio0.39%0.44%
Net assets, as of Oct 27, 2026$13.2bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, EMB and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first EMB IBB
Only in one fund ↓
Only in EMB
ARGENTINA REPUBLIC OF GOVERNMENT 1.08%
ECUADOR REPUBLIC OF (GOVERNMENT) RegS 0.76%
ARGENTINA REPUBLIC OF GOVERNMENT 0.65%
ARGENTINA REPUBLIC OF GOVERNMENT 0.64%
GHANA (REPUBLIC OF) DISCO RegS 0.56%
URUGUAY (ORIENTAL REPUBLIC OF) 0.54%
ARGENTINA REPUBLIC OF GOVERNMENT 0.52%
EAGLE FUNDING LUXCO SARL RegS 0.52%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

EMB iShares J.P. Morgan USD Emerging Markets Bond ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks the J.P. Morgan USD Emerging Markets Bond Biotech
Total return, 1 year −0.4% +37.5%
Expense ratio 0.39% 0.44%
Holdings 622 245
Net assets, EMB as of Oct 28, 2026 and IBB as of Oct 27, 2026 $13.2bn $11.0bn

EMB and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

EMB and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
EMB

EMB tracks the J.P. Morgan USD Emerging Markets Bond. Over the year to Oct 28, 2026 it returned −0.4% with distributions reinvested. The prospectus expense ratio is 0.39% a year. It sat 3.5% below its high of Jun 29, 2026 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are EMB and IBB in the same category?
EMB is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, EMB or IBB?
In the year to Oct 28, 2026, with distributions reinvested, EMB returned −0.4% and IBB +37.5%.
Which is cheaper, EMB or IBB?
EMB is cheaper, by 0.05 percentage points a year. That is about $5 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, EMB against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/emb-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.